{"id":"W1867789233","doi":"10.1200/jco.2012.30.15_suppl.lba1","title":"Primary results from EMILIA, a phase III study of trastuzumab emtansine (T-DM1) versus capecitabine (X) and lapatinib (L) in HER2-positive locally advanced or metastatic breast cancer (MBC) previously treated with trastuzumab (T) and a taxane.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lapatinib; Capecitabine; Medicine; Trastuzumab emtansine; Trastuzumab; Oncology; Internal medicine; Metastatic breast cancer; Breast cancer; Cancer; Gynecology; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003163477,0.001529285,0.002387598,0.0004424829,0.0005156961,0.001144213,0.001205447,0.00141332,0.01341685],"category_scores_gemma":[0.002888942,0.0005880497,0.002318059,0.0005055508,0.0004433949,0.000765676,0.0003165335,0.003855906,0.002993631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008636374,"about_ca_system_score_gemma":0.001214891,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001147304,"about_ca_topic_score_gemma":0.004244396,"domain_scores_codex":[0.9993126,0.0003878341,0.00004390616,0.00008096839,0.0000646,0.0001100436],"domain_scores_gemma":[0.9985111,0.0004750416,0.0002566281,0.0001315016,0.0001240637,0.000501628],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7873456,0.03356715,0.00327078,0.003106685,0.004562411,0.0003057728,0.0001746902,0.002307384,0.01705121,0.0003394422,0.0477806,0.1001883],"study_design_scores_gemma":[0.7478502,0.1987807,0.02485818,0.0002769894,0.004438878,0.0004070844,0.00007182956,0.0006395514,0.004205987,0.0003400666,0.0180801,0.0000503469],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7795911,0.06699932,0.003186059,0.005679206,0.003047526,0.01830182,0.06385134,0.0007486811,0.05859501],"genre_scores_gemma":[0.8626601,0.02532184,0.005501282,0.01120967,0.001923882,0.008064967,0.04932524,0.0002938454,0.03569922],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01341685,"threshold_uncertainty_score":0.04488385,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.120029974007668,"score_gpt":0.4837508507159989,"score_spread":0.363720876708331,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}